![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Achkar JM, Fries BC. 2010. Candida infections of the genitourinary tract. Clinical Microbiology Reviews 23:253–273.
- Auler ME, Morreira D, Rodrigues FF, Abr Ao MS, Margarido PF, Matsumoto FE et al. 2010. Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis. Medical Mycology 48:211–216.
- Blankenship JR, Mitchell AP. 2006. How to build a biofilm: a fungal perspective. Current Opinion in Microbiology 9:588–594.
- Caliskan S, Keceli Ozcan S, Cinar S, Corakci A, Caliskan E 2011. In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints. Mikrobiyoloji Bulteni 45:697–706.
- Chassot F, Negri MF, Svidzinski AE, Donatti L, Peralta RM, Svidzinski TI et al. 2008. Can intrauterine contraceptive devices be a Candida albicans reservoir? Contraception 77:355–359.
- Douglas LJ. 2003. Candida biofilms and their role in infection. Trends in Microbiology 11:30–36.
- Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. 2013. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. Journal of Lower Genital Tract Dısease 17:340–345.
- Li X, Yan Z, Xu J 2003. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 149:353–362.
- Mahmoudi Rad M, Zafarghandi A, Amel Zabihi M, Tavallaee M, Mirdamadi Y 2012. Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR. Infectious Disease in Obstetrics and Gynecology 2012:872169.
- Mazaheritehrani E, Sala A, Orsi CF, Neglia RG, Morace G, Blasi E et al. 2014. Human pathogenic viruses are retained in and released by Candida albicans biofilm in vitro. Virus Research 179:153–160.
- McClelland RS, Richardson BA, Hassan WM, Graham SM, Kiarie J, Baeten JM et al. 2009. Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis. Journal of Infectious Dıseases 199:1883–1890.
- Mukherjee PK, Zhou G, Munyon R, Ghannoum MA. 2005. Candida biofilm: a well-designed protected environment. Medical Mycology 43:191–208.
- Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology 29:297–301.
- Pammi M, Liang R, Hicks J, Mistretta TA, Versalovic J. 2013. Biofilm extracellular DNA enhances mixed species biofilms of Staphylococcus epidermidis and Candida albicans. BMC Microbiology 13:257.
- Pruthi V, Al-Janabi A, Pereira BM. 2003. Characterization of biofilm formed on intrauterine devices. Indian Journal of Medical Microbiology 21: 161–165.
- Ramage G, Martinez JP, Lopez-Ribot JL. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. Fems Yeast Research 6: 979–986.
- Sivin I, Batar I 2010. State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices. European Journal of Contraception and Reproductive Health Care 15:96–112.
- Sobel JD. 2007. Vulvovaginal candidosis. Lancet, 369:1961–1971.
- Xu H, Sobue T, Thompson A, Xie Z, Poon K, Ricker A et al. 2014. Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. Cellular Microbiology 16:214–231.